MSF Field Research > 1 Published Research and Commentary > Leishmaniasis/Kala Azar > Who Is a Typical Patient with Visceral Leishmaniasis? Characterizing the Demographic and Nutritional Profile of Patients in Brazil, East Africa, and South Asia

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/141430
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
110401_Harhay_Who-is-a-Typical-VL-Patient_Am-J-Trop-Med-Hyg-84-4-543-550.pdfMain Article786KbAdobe PDF

Title: Who Is a Typical Patient with Visceral Leishmaniasis? Characterizing the Demographic and Nutritional Profile of Patients in Brazil, East Africa, and South Asia
Authors: Harhay, Michael O
Olliaro, Piero L
Vaillant, Michel
Chappuis, François
Lima, María Angeles
Ritmeijer, Koert
Costa, Carlos Henrique
Costa, Dorcas Lamounier
Rijal, Suman
Sundar, Shyam
Balasegaram, Manica
Affiliation: Graduate Group in Demography, University of Pennsylvania, Philadelphia, Pennsylvania; United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland; Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom; Clinical Epidemiology and Public Health Unit, Center for Health Studies, Centre de Recherche Publique (CRP-Santé), Luxembourg; Médecins Sans Frontières, Operational Centre Geneva (MSF-OCG), Geneva, Switzerland; Division of International and Humanitarian Medicine, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; Médecins Sans Frontières, Operational Centre Barcelona-Athens (MSF-OCBA), Barcelona, Spain; Médecins Sans Frontières, Operational Centre Amsterdam (MSF-OCA), Amsterdam, The Netherlands; Instituto de Doenças Tropicais Natan Portella, Teresina, Piauí, Brazil; Federal University of Piauí, Piauí, Brazil; Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Department of Internal Medicine, B. P. Koirala Institute of Health Sciences, Dharan, Nepal; Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
Citation: Am J Trop Med Hyg 2011;84(4):543-550
Journal: The American Journal of Tropical Medicine and Hygiene
Issue Date: 1-Apr-2011
URI: http://hdl.handle.net/10144/141430
DOI: 10.4269/ajtmh.2011.10-0321
PubMed ID: 21460007
Additional Links: http://www.ajtmh.org/cgi/content/abstract/84/4/543
Abstract: Abstract. Drug-dosing recommendations for visceral leishmaniasis (VL) treatment are based on the patients' weight or age. A current lack of demographic and anthropometric data on patients hinders (1) the ability of health providers to properly prepare for patient management, (2) an informed drug procurement for disease control, and (3) the design of clinical trials and development of new drug therapies in the different endemic areas. We present information about the age, gender, weight, and height of 29,570 consecutive VL patients presenting to 20 locations in six geographic endemic regions of Brazil, East Africa, Nepal, and India between 1997 and 2009. Our compilation shows substantial heterogeneity in the types of patients seeking care for VL at the clinics within the different locations. This suggests that drug development, procurement, and perhaps even treatment protocols, such as the use of the potentially teratogenic drug miltefosine, may require distinct strategies in these geographic settings.
Type: Article
Language: en
MeSH: Visceral Leishmaniasis
Nutritional Status
Demography
ISSN: 1476-1645
Rights: Archived with thanks to The American Journal of Tropical Medicine and Hygiene
Appears in topics: Leishmaniasis/Kala Azar

Related articles on PubMed
bullet
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M
2009
bullet
bullet
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal.
Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, Paudel IS, Andersen EW, Meheus F, Ostyn B, Das ML, Davies C, Boelaert M
2010 Jul
bullet
Visceral leishmaniasis in Nepal during 1980-2006.
Joshi DD, Sharma M, Bhandari S
2006 Mar
bullet
See all 86 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Nov 1, 2014